Health Condition 1: J989- Respiratory disorder, unspecified
Conditions
Interventions
Intervention1: Ashwagandhadi Avaleha: Ashwagandhadi Avaleha
10gm BD
along with Anti Tubercular Treatment (HRZE)
for 8 weeks(intensive phase of ATT regimen)
Control Intervention1: HRZE(Isoniazid, Ri
Sponsors
Principal
Eligibility
Inclusion criteria
Inclusion criteria: 1. Freshly diagnosed cases of tuberculosis(Pulmonary Tuberculosis and Tubercular pleural effusion) 2. Patients of either sex between the age of 15-70 years. 3. Patients willing and able to participate for 8 weeks duration
Exclusion criteria
Exclusion criteria: 1. MDR and XDR cases of tuberculosis. 2. Patients having diabetes mellitus. 3. Patient with uncontrolled hypertension. 4. Suffering from any other chronic infections including HIV. 5. Patients Below the age of 15yrs and above the age of 70yrs. 6. Patients not willing for trial. 7. Individuals who have completed participation in any other clinical trial during the past three months. 8. Any other condition which the Principal investigator thinks may jeopardize the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of Ashwagandhadi Avaleha to reduce/prevent toxicity when administered as add on therapy along with Anti tubercular drugs in the management of TuberculosisTimepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy of the Ashwagandhadi Avaleha in improving general well being.Timepoint: 8 weeks | — |
Countries
India
Contacts
Public ContactDr Pratibha Thakur
RGGPG Ayurvedic College and Hospital , Paprola
Outcome results
None listed